Ventyx Biosciences Inc (VTYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -135,122 | -192,962 | -108,426 | -83,746 | -28,174 |
| Depreciation Amortization | 1,348 | 941 | 470 | 30 | N/A |
| Accounts payable and accrued liabilities | -2,644 | -745 | 1,613 | 2,443 | 591 |
| Other Working Capital | -10,563 | 5,806 | -5,157 | 4,016 | 811 |
| Other Operating Activity | 16,108 | 20,438 | 12,729 | 38,607 | 20,577 |
| Operating Cash Flow | $-130,873 | $-166,522 | $-98,771 | $-38,650 | $-6,195 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,265 | 101,454 | -74,656 | -216,002 | 0 |
| PPE Investments | -241 | -514 | -275 | -262 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 1,899 | N/A |
| Investing Cash Flow | $-15,506 | $100,940 | $-74,931 | $-214,365 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 450 | 6,128 |
| Common Stock Issued | 95,512 | 53,329 | 167,772 | 158,880 | 2 |
| Other Financing Activity | 26,603 | 0 | 0 | 164,221 | 0 |
| Financing Cash Flow | $122,115 | $53,329 | $167,772 | $323,551 | $6,130 |
| Exchange Rate Effect | -55 | -12 | -42 | 11 | N/A |
| Beginning Cash Position | 52,554 | 64,819 | 70,791 | 244 | 309 |
| End Cash Position | 28,235 | 52,554 | 64,819 | 70,791 | 244 |
| Net Cash Flow | $-24,319 | $-12,265 | $-5,972 | $70,547 | $-65 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130,873 | -166,522 | -98,771 | -38,650 | -6,195 |
| Capital Expenditure | -241 | -514 | -275 | -262 | 0 |
| Free Cash Flow | -131,114 | -167,036 | -99,046 | -38,912 | -6,195 |